<DOC>
	<DOCNO>NCT02969304</DOCNO>
	<brief_summary>The primary objective study estimate proportion DMF use prescribe `` on-label '' versus `` off-label '' . The secondary objective : To describe demographic characteristic medical history DMF user ; To describe prescription drug history concomitant medication use DMF user ; To describe duration therapy participant newly initiate DMF treatment ; To describe medical specialty DMF prescribers .</brief_summary>
	<brief_title>Study Utilization Patterns Dimethyl Fumarate Germany</brief_title>
	<detailed_description>Dimethyl fumarate provide participant part study .</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Key New user dimethyl fumarate include analysis Key Patients data available 6 month period prior index date ( baseline observational period ) NOTE : Other protocol define Inclusion/ Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tecfidera</keyword>
	<keyword>Off-label</keyword>
	<keyword>Utilization</keyword>
</DOC>